Kezar Life Sciences (KZR) Depreciation & Amortization (CF) (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Depreciation & Amortization (CF) for 5 consecutive years, with $176000.0 as the latest value for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 32.05% year-over-year to $176000.0; the TTM value through Dec 2025 reached $897000.0, down 13.75%, while the annual FY2025 figure was $897000.0, 13.75% down from the prior year.
  • Depreciation & Amortization (CF) hit $176000.0 in Q4 2025 for Kezar Life Sciences, down from $227000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $458000.0 in Q3 2022 and bottomed at -$283000.0 in Q4 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $276800.0, with a median of $260500.0 recorded in 2024.
  • Year-over-year, Depreciation & Amortization (CF) crashed 173.13% in 2022 and then soared 198.94% in 2023.
  • Kezar Life Sciences' Depreciation & Amortization (CF) stood at $387000.0 in 2021, then crashed by 173.13% to -$283000.0 in 2022, then skyrocketed by 198.94% to $280000.0 in 2023, then dropped by 7.5% to $259000.0 in 2024, then tumbled by 32.05% to $176000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $176000.0, $227000.0, and $243000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.